Feedback / Questions
SCN-1 - Scinai Immunotherap
https://www.prnewswire.com/news-releases/scinai-immunotherapeutics-announces-positive-regulatory-feedback-from-the-pei-on-the-path-for-phase-12a-in-plaque-psoriasis-with-its-anti-il-17-nanoab-302203713.html
Jul 23, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next